Value articulation: Aframework for the strategic management of intellectual property

California Management Review

Volumn 55, Issue 4, 2013, Pages 102-120

  Conley, James G ^a   Bican, Peter M ^a,b   Ernst, Holger ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WHU OTTO BEISHEIM SCHOOL OF MANAGEMENT   (Germany)

Author keywords

Brand equity; Case method; Intellectual property; Licensing; Marketing; Multiple industries; Patents; Product life cycle; Strategic management; Value transference

Indexed keywords

EID: 84912526995     PISSN: 00081256     EISSN: 21628564     Source Type: Journal    
DOI: 10.1525/cmr.2013.55.4.102     Document Type: Article

References (71)

1. Robert Merges, "Uncertainty and the Standard of Patentability", High Technology Law Journal, 7(Spring 1992):1-70.
2. James G. Conley and John Szobocsan, "Snow White Shows the Way", Managing Intellectual Property, 6(June 2001):1-5;
3. Meir Statman and Tyzoon T. Tyebjee, "Trademarks, Patents, and Innovation in the Ethical Drug Industry", Journal of Marketing, 45/3(Summer 1981):71-81;
4. Gideon Parchomovsky and Peter Siegelman, "Towards an Integrated Theory of Intellectual Property", Virginia Law Review, 88/7(November 2002):1455-1528;
5. Ove Granstrand, The Economics and Management of Intellectual Property: Towards Intellectual Capitalism (Cheltenham, UK: Edward Elgar, 1999);
6. Klaus Jennewein, Intellectual Property Management: The Role of Technology-Brands in the Appropriation of Technological Innovation (Heidelberg: Physica-Verlag, 2005);
7. David J. Teece, "Profiting from Technological Innovation: Implications for Integration, Collaboration, Licensing and Public Policy", Research Policy, 15/6(December 1986):285-305;
8. Gary Pisano and David J. Teece, "How to Capture Value from Innovation: Shaping Intellectual Property and Industry Architecture", California Management Review, 50/1(Fall 2007):278-296.
9. Philip Kotler and Waldemar Pfoertsch, Ingredient Branding: Making the Invisible Visible (Heidelberg: Springer, 2010);
10. th edition (Upper Saddle River, NJ: Prentice Hall, 2011);
11. Alokparna Basu Monga and Deborah Roedder John, "What Makes Brands Elastic? The Influence of Brand Concept and Styles of Thinking on Brand Extension Evaluation", Journal of Marketing, 74/3(May 2010):80-92;
12. Janell D. Townsend, Sengun Yeniyurt, and Mehmet Berk Talay, "Getting to Global: An Evolutionary Perspective of Brand Expansion in International Markets", Journal of International Business Studies, 40/4(May 2009):539-558;
13. Srinivas K. Reddy, Susan L. Holak, and Subodh Bhat, "To Extend or Not to Extend: Success Determinants of Line Extensions", Journal of Marketing Research, 31/2(May 1994):241-262.
14. Kalpesh Kaushik Desai and Kevin Lane Keller, "The Effects of Ingredient Branding Strategies on Host Brand Extendibility", Journal of Marketing, 66/1(January 2002):73-93.
15. David A. Aaker and Alexander L. Biel, eds., Brand Equity and Advertising: Advertising's Role in Building Strong Brands (Hillsdale, NJ: Lawrence Erlbaum Associates, 1993).
16. A colored depiction of the figures included in this paper can be accessed under , accessed on June 24, 2013.
17. Rosser Reeves, Reality in Advertising (New York, NY: Alfred A. Knopf, 1961);
18. Jack Trout, Differentiate or Die: Survival in Our Era of Killer Competition (New York, NY: John Wiley & Sons, 2000).
19. Patent Number US3, 475, 403, source: USPTO.
20. "History in the Making: The Most Significant Promotions of the Last 15Years", Chief Marketer Network, March 1, 2002, , accessed on May 15, 2012.
21. James G. Conley, J. Duncan Berry, Laura DeWitt, and Mark Dziersk, "Inventing Brands: Opportunities at the Nexus of Semiotics and Intellectual Property", Design Management Review, 19/2(Spring 2008):58-67.
22. For additional information, see also Daniel Charles, Lords of the Harvest (New York, NY: Perseus Books Group, 2001);
23. Brian Hindo, "Monsanto: Winning the Ground War", Businessweek, December 6, 2007, , accessed on May 15, 2012.
24. Patent Number US4, 405, 356, source: USPTO.
25. Roundup TM Registration Number 0847249, source: USPTO.
26. For additional information on how patents are linked to trademarks at Monsanto, see the Monsanto Technology/Stewardship Agreement 2010, , accessed November 16, 2012;
27. the Technology Use Guide 2010, , accessed November 16, 2012. Roundup Ready TM Registration Number 0847249, source: USPTO.
28. Patent Number US4, 255, 431, source: USPTO.
29. Robert Bazell, "The Costly Side Effects of Nexium's Ad Blitz", msnbc.com, August 14, 2007, , accessed on May 15, 2012.
30. Dipak C. Jain and James G. Conley, "Patent Expiry and Pharmaceutical Market Opportunities at the Nexus of Pricing and Innovation Policy", INSEAD Working Paper 2012/89/MKT, 2012, , accessed November 14, 2012.
31. Patent Number US5, 714, 504, source: USPTO.
32. U. S Food and Drug Administration, Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, updated May 18, 2012, , accessed on May 18, 2012.
33. U. S Food and Drug Administration, Prilosec OTC (omeprazole) Information, updated September 21, 2010, , accessed on November 16, 2012.
34. Advanstar Communications, DrugTopics: TOP 200 OTC/HBC Brands in 2007, February 25, 2008, , accessed on May 15, 2012.
35. Gianluca Sergi, The Dolby Era (Manchester: Manchester University Press, 2004).
36. Craig Karmin, "Dolby Labs Buys Naming Rights for Theater that Hosts Oscars", The Wall Street Journal, May 1, 2012, , accessed on May 15, 2012.
37. Patent Number GB1, 120, 541, source: Espacenet.
38. Interview with Ray Dolby in Sergi, op. cit.
39. Patent Number US3, 631, 365 and US3, 846, 719, source: USPTO.
40. Dolby Laboratories Inc., Press Release: Dolby Surpasses Major Milestone: One Billion Licensed Products Sold, May 15, 2002, , accessed on May 15, 2012.
41. See B-Type and C-Type Noise Reduction Systems License Agreement Consumer Audio Hardware, included in: Dolby Laboratories Inc., Amendment No. 1 To Form S-1 Registration Statement, filed with the SEC on December 30, 2004, , accessed on March 12, 2013.
42. Ian Hardcastle, "Commercializing the Dolby System", 2003, , accessed on May 15, 2012.
43. Interview with Ray Dolby in Sergi, op. cit.
44. Dolby Digital Decoder Patents (see Onecle Inc., Sample Business Contracts: Dolby System License Agreement of May 20, 2004, 2012, , accessed on July 8, 2012): US4, 790, 016, US4, 914, 701, US5, 357, 594, US5, 479, 562, US5, 633, 981, US5, 109, 417, US5, 235, 671, US5, 274, 740, US5, 291, 557, US5, 297, 236, US5, 394, 473, US5, 581, 653, US5, 583, 962, US5, 623, 577, US5, 632, 003, US5, 752, 225, US5, 890, 106, US6, 449, 368, source: USPTO.
45. Other deficiencies of the CDS system might also have played a strong role in its decline. See Mark Kerins, Beyond Dolby (Bloomington, IN: Indiana University Press, 2011).
46. Ray Dolby and Ioan Allen of Dolby Labs were awarded the Academy Award of Merit (Oscar) in 1988 for their continuous contributions to motion picture sound. See Dolby Laboratories Inc., "Academy Awards, 2013", , accessed on March 14, 2013.
47. Moving into the professional film market and continuously building on the benefits of the Dolby IP, the early Dolby noise reduction and Dolby Stereo System set the stage for marking the year 2012 as the 34th consecutive season that films released with Dolby audio technologies have earned Academy Award nominations for outstanding sound quality. See Dolby Laboratories Inc., "Press Release: Dolby Congratulates Oscar-Nominated Sound Editors, Mixers, and Cinematographers", February 22, 2012, , accessed on May 15, 2012.
48. For an extended visualization of Dolby's IP and business activities over time, see , accessed on November 16, 2012.
49. The Nespresso case study demonstrating the value articulation framework in a FMCG/CPG context can be accessed online under , accessed on March 14, 2013.
50. Ammon Salter and Bruce S. Tether, "Innovation in Services: Through the Looking Glass of Innovation Studies", background paper for Advanced Institute of Management (AIM) Research's Grand Challenge on Service Science, Oxford, Saïd Business School, 2006, pp. 1-38;
51. Petr Hanel, "Intellectual Property Rights Business Management Practices: A Survey of the Literature", Technovation, 26/8(August 2006):895-931; Jennewein, op. cit.
52. Value transportation in the pharmaceutical industry does not only apply to already approved, ready-to-market or already successfully marketed drugs. Even compounds, which have been abandoned during development, could be transported further, see Henry Chesbrough and Eric L. Chen, "Recovering Abandoned Compounds Through Expanded External IP Licensing", California Management Review, 55/4 (Summer 2013).
53. W. C. Kim and R. Mauborgne, "Blue Ocean Strategy: From Theory to Practice", California Management Review, 47/3(Spring 2005):105-121;
54. Mehrdad Baghai, Steve Coley, and David White, The Alchemy of Growth (New York, NY: Perseus Publishing, 2000).
55. William W. Fisher III and Felix Oberholzer-Gee, "Strategic Management of Intellectual Property: An Integrated Approach", California Management Review, 55/4 (Summer 2013).
56. Summary of teaching resources for AstraZeneca: James G. Conley, "AstraZeneca, Prilosec, and Nexium: Strategic Challenges in the Launch of a Second-Generation Drug", Kellogg Case Study, distributed through HBS, version 5-404-752, revised April 2005;
57. James G. Conley, "Case Supplement: AstraZeneca, Prilosec, and Nexium", Kellogg Case Study Supplement, distributed through HBS, version 5-404-753, 2006; Jain and Conley, op. cit. Teaching Resources for Dolby Labs: Sergi, op. cit.; Kerins, op. cit.;
58. Pamela Hawkins Williams, Dotcy Isom III, and Tiffini D. Smith-Peaches, "A Profile of Dolby Laboratories: An Effective Model for Leveraging Intellectual Property", Northwestern Journal of Technology and Intellectual Property, 2/1(Fall 2003):81-98.
59. For an extended visualization of Dolby's IP and business activities over time, see , accessed on November 16, 2012.
60. Disney Consumer Products, About US, 2012, , accessed on November 12, 2012.
61. In one of their licensing contracts for Disney's George of the Jungle, Disney displays the extension of their copyrights, their core IP, via trademarks as following: "In consideration for licensee's payments... Disney grants Licensee the non-exclusive right... to reproduce the licensed material [defined as the graphic representations, i.e., the copyrighted works]... in connection with the articles [defined as the following items on... which the licensed material and/or the trademarks are reproduced, here binders, study kits and so forth], to use such trademarks and uses thereof... to manufacture... the articles." See Disney License Agreement, December 14, 1996, , accessed on November 12, 2012.
62. Statista, Global Revenue of the Walt Disney Company from 2006 to 2012, 2012, , accessed November 15, 2012;
63. The Wrap Media, Report: Disney Raked in $28.6B From Licensed Merchandise in 2010, May 2011, , accessed on November 15, 2012.
64. Fabrizio Cesaroni and Andrea Piccaluga, "Operational Challenges and ST's Proposed Solutions to Improve Collaboration between IP and R&D in Innovation Processes", California Management Review, 55/4 (Summer 2013); Fisher and Oberholzer-Gee, op. cit.
65. Personal interview with Gerhard Berssenbrügge, 2012.
66. Holger Ernst and Martin Fischer, "Integrating the R&D and Patent Functions: Implications for New Product Performance", Journal of Product Innovation Management (forthcoming).
67. Personal interview with Robert Shapiro, 2012.
68. For additional information, see Henry C. Lucas Jr. and Jie Mein Goh, "Disruptive Technology: How Kodak Missed the Digital Photography Revolution", The Journal of Strategic Information Systems, 18/1(March 2009):46-55.
69. Personal interview with Ed Schummer, 2012.
70. For example, The Nortel Patent Portfolio was won in an auction by a consortium including, among others, Apple, RIM, and Microsoft for $4.5 billion, granting access to more than 6.000 patents and applications, see "UPDATE 1-Apple, RIM in Consortium Buying Nortel's Patent Portfolio", Reuters, July 1, 2011, , accessed on May 15, 2012;
71. Microsoft acquired a portfolio of patents from AOL for $ 1 billion, selling a portion to Facebook for $0.5 billion, see "Microsoft to Sell Some AOL Patents to Facebook for $550M", Forbes, April 23, 2012, , accessed on May 15, 2012.